» Articles » PMID: 36331285

Circ_0000284 Facilitates the Growth, Metastasis and Glycolysis of Intrahepatic Cholangiocarcinoma Through MiR-152-3p-mediated PDK1 Expression

Overview
Date 2022 Nov 4
PMID 36331285
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Circular RNAs (circRNAs) are key molecules in the regulation of intrahepatic cholangiocarcinoma (ICC) progression. The purpose of this study was to analyze the function and underlying molecular mechanism of circ_0000284 in ICC.

Methods: Quantitative real-time PCR was used to analyze the circ_0000284, microRNA (miR)-152-3p and pyruvate dehydrogenase kinase 1 (PDK1) expression. Cell proliferation, apoptosis, invasion and migration were executed by cell counting kit 8 assay, EdU assay, flow cytometry, transwell assay and wound healing assay, respectively. All protein expression levels were examined using western blot analysis. Cell glycolysis was analyzed by detecting glucose consumption, lactate production and ATP/ADP ratios. Target relationship was estimated by dual-luciferase reporter assay. The effect of circ_0000284 on ICC tumor growth in vivo was evaluated by constructing xenograft mice model.

Results: We detected high expression of circ_0000284 in ICC tumor tissues and cells. Downregulated circ_0000284 inhibited ICC cell proliferation, invasion, migration, glycolysis, and accelerated apoptosis. MiR-152-3p was sponged by circ_0000284, and its inhibitor revoked the effect of circ_0000284 knockdown on ICC cell progression. PDK1 was a target of miR-152-3p, and its expression was suppressed by circ_0000284 knockdown. PDK1 overexpression reversed the inhibition effect of miR-152-3p on ICC cell growth, metastasis and glycolysis. In animal experiments, circ_0000284 downregulation also inhibited ICC tumor growth.

Conclusion: Circ_0000284 promoted the growth, metastasis and glycolysis of ICC by miR-152-3p/PDK1 pathway, showing that circ_0000284 was a potential therapeutic target for ICC.

Citing Articles

The dual role of circHIPK3 in cancer and its implications for multiple drugs resistance: a systematic review and computational approach.

Campelo M, Reis-das-Merces L, Vidal A, da Silva F, de Oliveira A, Monteiro J Front Oncol. 2025; 15:1547889.

PMID: 40061896 PMC: 11885226. DOI: 10.3389/fonc.2025.1547889.


The prognosis of ciRS-7 and circHIPK3 in pan-cancer: a mini-review and meta-analysis.

Li X, Wu T, Dong R, Wu X Discov Oncol. 2025; 16(1):207.

PMID: 39969753 PMC: 11839969. DOI: 10.1007/s12672-025-01944-2.


Circ_0000284 Is Involved in Arsenite-Induced Hepatic Insulin Resistance Through Blocking the Plasma Membrane Translocation of GLUT4 in Hepatocytes via IGF2BP2/PPAR-γ.

Xu S, Hu Z, Wang Y, Zhang Q, Wang Z, Ma T Toxics. 2025; 12(12.

PMID: 39771098 PMC: 11679219. DOI: 10.3390/toxics12120883.


Targeting Glycolytic Reprogramming in Cholangiocarcinoma: A Novel Approach for Metabolic Therapy.

Hao L, Li S, Peng Q, Zhang J, Deng J, Hu X J Inflamm Res. 2024; 17:9665-9681.

PMID: 39618935 PMC: 11606715. DOI: 10.2147/JIR.S497551.

References
1.
Altesha M, Ni T, Khan A, Liu K, Zheng X . Circular RNA in cardiovascular disease. J Cell Physiol. 2018; 234(5):5588-5600. DOI: 10.1002/jcp.27384. View

2.
Braconi C, Huang N, Patel T . MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes. Hepatology. 2010; 51(3):881-90. PMC: 3902044. DOI: 10.1002/hep.23381. View

3.
Chen B, Huang S . Circular RNA: An emerging non-coding RNA as a regulator and biomarker in cancer. Cancer Lett. 2018; 418:41-50. DOI: 10.1016/j.canlet.2018.01.011. View

4.
Chen L . The expanding regulatory mechanisms and cellular functions of circular RNAs. Nat Rev Mol Cell Biol. 2020; 21(8):475-490. DOI: 10.1038/s41580-020-0243-y. View

5.
Chen Q, Wang H, Li Z, Li F, Liang L, Zou Y . Circular RNA ACTN4 promotes intrahepatic cholangiocarcinoma progression by recruiting YBX1 to initiate FZD7 transcription. J Hepatol. 2021; 76(1):135-147. DOI: 10.1016/j.jhep.2021.08.027. View